AstraZeneca & Sanofi
10 shared events · Importance 3 · Last updated Aug 19, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
AstraZeneca: AstraZeneca licensed TQC3721, an inhaled PDE3/4 inhibitor for COPD, from Sino Biopharmaceutical in a deal valued up to US$1.9 billion. This strengthens AstraZeneca's respiratory pipeline and aligns with its focus on chronic diseases.
Sanofi: Sanofi is a key partner, having licensed rovadicitinib from Sino Biopharmaceutical in a deal valued up to US$1.53 billion. This adds a promising asset to Sanofi's pipeline, potentially enhancing its respiratory and immunology portfolio.
Jul 20, 2026 · 6 articles
Business
AstraZeneca: AstraZeneca participated in the symposium, contributing to discussions on decarbonization and green chemistry.
Sanofi: Sanofi participated in the symposium, reflecting its interest in sustainable manufacturing technologies.
Jul 20, 2026 · 6 articles
Regulatory
AstraZeneca: AstraZeneca's flu vaccine portfolio could be affected by the entry of mFLUSIVA.
Sanofi: Sanofi's high-dose flu vaccine served as a comparator in trials; the new mRNA vaccine may compete with its products.
Aug 05, 2026 · 105 articles
Regulatory
AstraZeneca: AstraZeneca is mentioned as a collaborator with Innate Pharma, specifically on the monalizumab antibody.
Sanofi: Sanofi is mentioned as a collaborator with Innate Pharma in immuno-oncology.
Apr 02, 2026 · 7 articles
Business
AstraZeneca: AstraZeneca is mentioned as a collaborator with Innate Pharma, specifically on the monalizumab antibody for non-small cell lung cancer.
Sanofi: Sanofi is mentioned as a collaborator with Innate Pharma, indicating existing partnerships in immuno-oncology.
Apr 08, 2026 · 6 articles
Business
AstraZeneca: Collaborator with Innate on monalizumab, mentioned as part of Innate's partnered assets, not directly affected by this deal.
Sanofi: Mentioned as a collaborator with Innate, not directly involved in this partnership.
Aug 10, 2026 · 10 articles
Regulatory
AstraZeneca: AstraZeneca is mentioned as a biopharmaceutical company with whom Innate Pharma has established collaborations, including the development of monalizumab.
Sanofi: Sanofi is mentioned as a biopharmaceutical company with whom Innate Pharma has established collaborations.
Apr 13, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how AstraZeneca and Sanofi interact across events, view sentiment trends, and discover connected entities.
Open Dashboard